Showing 3151-3160 of 5621 results for "".
- Regenxbio Announces Additional Positive Interim Phase 1/2a Trial Update for RGX-314 for the Treatment of Wet AMDhttps://modernod.com/news/regenxbio-announces-additional-positive-interim-phase-1-2a-trial-update-for-rgx-314-for-the-treatment-of-wet-amd-2/2478113/Regenxbio reported positive 1 year data from patients in Cohorts 4 and 5 of the phase 1/2a trial of RGX-314 for the treatment of wet age-related macular degeneration (AMD). The company plans to initiate a pivotal program for subretinal delivery of RGX-314 in patients with wet AMD by the end of 20
- Can You Get COVID-19 Through Your Eyes? Possibly.https://modernod.com/news/can-you-get-covid-19-through-your-eyes-possibly/2478112/We know that the coronavirus can enter the body through the nose and mouth — hence the constant recommendations from doctors to wear face coverings and practice social distancing. But what abou
- Some Providers Face Daunting Repayment Deadline for Medicare Advance Loanshttps://modernod.com/news/some-providers-face-daunting-repayment-deadline-for-medicare-advance-loans/2478108/Starting this month, some providers are facing the prospect of their Medicare payments garnished to repay COVID-19 loans, according to a FierceHealthcare
- Senate GOP Outlines Next Coronavirus Relief Bill as Deadline for Enhanced Unemployment Benefits Nearshttps://modernod.com/news/senate-gop-outlines-next-coronavirus-relief-bill-as-deadline-for-enhanced-unemployment-benefits-nears/2478090/Senate Republicans outlined their fourth phase of federal coronavirus response efforts, rolling out their legislative package as enhanced unemployment benefits are beginning to expire for millions of Americans who are out of work due to the coronavirus pandemic, accordin
- Hanita Lenses Announces Launch of Intensity IOLhttps://modernod.com/news/hanita-lenses-announces-launch-of-intensity-iol/2478082/After 3 years of development, Israel-based Hanita Lenses announced the launch of the Intensity IOL. The Intensity is a presbyopia-correcting IOL that has been developed by employing a proprietary iterative algorithm—called the Dynamic Light Utilization (DLU) technology—for better light eff
- NowRx, Medly Pharmacy Land New Funding as Demand for Digital Pharmacies Growshttps://modernod.com/news/nowrx-medly-pharmacy-land-new-funding-as-demand-for-digital-pharmacies-grows/2478052/Digital pharmacy startups taking on industry giants CVS and Walgreens are securing sizable sums of money from investors, according to a FierceHealthcare
- A Potential New Approach to Combat Drug Resistance in Age-Related Macular Degenerationhttps://modernod.com/news/a-potential-new-approach-to-combat-drug-resistance-in-age-related-macular-degeneration/2478031/An international team of researchers led by Baylor College of Medicine and Houston Methodist has discovered a strategy that can potentially address a major challenge to the current treatment for choroidal neovascularization (CNV), according to a university news release. Anti-vascular endot
- Looking out for You | A Message From Ophthalmologistshttps://modernod.com/news/looking-out-for-you-a-message-from-ophthalmologists/2478018/
- Looking out for You | A Message From Optometristshttps://modernod.com/news/looking-out-for-you-a-message-from-optometrists/2478019/
- Allscripts, Microsoft Strike 5-Year Cloud Partnership to Enhance EHR Softwarehttps://modernod.com/news/allscripts-microsoft-strike-5-year-cloud-partnership-to-enhance-ehr-software/2478012/Allscripts is extending its partnership with Microsoft to use the tech giant’s cloud technology to enhance its electronic health record (EHR) software, according to a FierceHealthcare